George Zhanel
- Clinical cure rates in patients treated with azithromycin (AZ) for lower respiratory infections (LRTI) caused by AZ-susceptible (AZ-S) and AZ-resistant (AZ-R) organisms: Analysis of phase 3 clinical trialsBy Alan Kaplan, George Zhanel, Christina Calciu and Wolter KevinAlan Kaplan1Family and Community Medicine, University of Toronto, Toronto, ON, CanadaGeorge Zhanel2Medical Microbiology/Infectious Diseases, Faculty of Medicine, University of Manitoba, Winnipeg, MB, CanadaChristina Calciu3Research, Pfizer Canada, Montreal, QC, CanadaWolter Kevin4Research, Pfizer United States, New York, NY,
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.